MIB Agents Funded Research

THE OUTSMARTING IMPACT

Launched in 2017 and powered by MIB Agents Family Funds, the OutSmarting Osteosarcoma Research Grant has fueled discovery by awarding $2.9 million to 37 dedicated investigators working to advance osteosarcoma research. But the impact of this investment extends far beyond these studies. As a result of OutSmarting Osteosarcoma's investment, MIB Agents funded studies have resulted in:

236 Presentations sharing findings with the scientific community

35 Publications disseminating findings into the public domain

10 clinical trials opened

$34.5 million secured in additional osteosarcoma research funding